Psilocybin's Impact on Depression and Anxiety in Cancer Patients: Study Findings
By
Bluestein
Pure flour-power. Hearty enough to carry you through lunch.
Summary
A randomized double-blind trial studied the effects of psilocybin on 51 cancer patients with symptoms of depression and anxiety. Results showed substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.
Key quotes
· 4 pulledPsilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer.
The effects of psilocybin were studied in 51 cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety.
This randomized, double-blind, cross-over trial investigated the effects of a very low (placebo-like) dose vs. a high dose of psilocybin.
Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·1h ago
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
biozentrum.unibas.ch·1h ago
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
bbc.co.uk·5h ago
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
newscientist.com·6h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h agoExperimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·6h ago